Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL248P (RNA, 7SL, cytoplasmic 248, pseudogene) is a pseudogene belonging to the family of 7SL RNA sequences, which are non-coding RNA segments that normally function as the RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex involved in the targeting of proteins to the endoplasmic reticulum in cells[1][5][6][7]. However, RN7SL248P itself does not produce a functional RNA or protein product. Instead, it is a truncated, non-functional genetic sequence arising from the retrotransposition or duplication of the original 7SL gene. Most 7SL-related sequences in the human genome are pseudogenes that are not expressed and do not participate in signal recognition particle activity[5][6][7]. There is no evidence implicating RN7SL248P in disease, therapeutic intervention, or biological processes, and it should not be considered a molecular or therapeutic target. Clarification: - RN7SL248P is not a receptor, enzyme, transporter, or transcription factor. - It is a truncated pseudogene, not an active molecular target[1][5][6][7]. - Most information about the 7SL RNA gene family relates to the functional genes or the general role of 7SL RNA, not to pseudogenes like RN7SL248P. - The entry is likely incorrect as a drug target; it is not druggable nor does it serve as a target for known drugs or biomarkers.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 248, pseudogene (RN7SL248P).